Connect Has A Best-In-Class Anti-IL-13 In Eczema, But Won’t Be Taking On Apogee Yet – Citeline News & Insights

eczemarelief

7 months ago

Connect Has A Best-In-Class Anti-IL-13 In Eczema, But Won’t Be Taking On Apogee Yet Citeline News & Insights

Source link

Previous Article

Expectations For Sanofi’s Dupixent Successor Drop On Latest Eczema Data – Citeline News & Insights

Next Article

When stress writes on the skin: the secret circuit that makes eczema explode – Il Sole 24 ORE